x

Posted 01 March, 2024

Safety Shot, Inc. appointed Jarrett Boon as new CEO

Nasdaq:SHOT appointed new Chief Executive Officer Jarrett Boon in a 8-K filed on 01 March, 2024.


  On February 28, 2024 the Board appointed Jarrett Boon as the Chief Executive Officer of the Company, effective immediately.  

Don't how to trade CEO change? Read Reasons for CEO Turnover and Effect on Stock Performance.
Overview of Safety Shot, Inc.
Health Care/Life Sciences • Pharmaceuticals
Jupiter Wellness, Inc. engages in the business of developing cannabidiol (CBD) based medical therapeutics and wellness products. It operates under the Sales and Development of CBD Based Skin Care and Therapeutic Products, and Sales and Merchandise Sold to Theme Parks segments. The company was founded by Brian S. John on October 24, 2018 and is headquartered in Jupiter, FL.
Market Cap
$90.7M
View Company Details
Relevant filing section
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers


On February 27, 2024, the board of directors (the "Board") appointed Danielle De Rosa as the Chief Financial Officer of the Company, effective March 1, 2024. Ms. Rosa has over 25 years of experience in all aspects of financial services and operational functions. Ms. Rosa served as Chief Financial Officer at Virtra since January 2023. From July 2022 to December 2022, Ms. Rosa served as the CFO at Common Spirit. From December 2010 to February 2022, Ms. Rosa served as the Senior Finance Officer at Lorts Manufacturing. Ms. Rosa has a Master of Business Management from University of Phoenix and a Bachelor of Science in Accounting from University of Phoenix. 


On February 28, 2024, Markita L. Russell resigned from her position as the Chief Financial Officer of the Company, effective February 29, 2024. Ms. Russell's resignation is not the result of any disagreement with the Company, the board of directors , or management, on any matter relating to the Company's operations, policies or practices.


On February 28, 2024, Brian S. John resigned from his position as the Chief Executive Officer of the Company, effective immediately. Mr. John's resignation is not the result of any disagreement with the Company, the Board, or management, or any matter relating to the Company's operations, policies or practices. On February 28, 2024, Mr. John resigned from the Board. The information contained in Item 1.01 to this current report on Form 8-K is by this reference incorporated in this Item 5.02.


On March 1, 2024, Dr. Glynn Wilson resigned his position from the Board and his role as Chairman of the Board. Mr. John Gulyas assumed the position of Chairman of the Board.


On February 28, 2024 the Board appointed Jarrett Boon as the Chief Executive Officer of the Company, effective immediately. Since the acquisition of GBB Drink Lab, he has been the Chief Operating Officer. Mr. Boon was the Co-Founder and CEO of GBB Drink Lab. Mr. Boon has over 30 years of experience building successful businesses from creation to exit. He was one of the original thought leaders and investors in LifeLock, a leading identity protection provider, where he applied his expertise in sales, marketing, and strategic business development to grow LifeLock to $500 million in revenue. LifeLock went public in 2012 and was subsequently acquired by Symantec in 2016 for $2.3 billion. Prior to LifeLock, Mr. Boon founded SW Promotions, a marketing and advertising company. SW Promotions and its 400 employees were acquired by one of its publicly traded partners.


There are no arrangements or understandings between the Company and the newly appointed executive officer or director and any other person or persons pursuant to which each executive officer or director was appointed and there is no family relationship between or among any director or executive officer of the Company or any person nominated or chosen by the Company to become a director or executive officer.


There are no transactions between the Company and any newly appointed executive officer or director that are reportable pursuant to Item 404(a) of Regulation SK. The Company did not enter into or materially amend any material plan, contract or arrangement with any newly appointed executive officer or director in connection with his or her appointment as a director or executive officer.